$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

The Effects of Adding Art Therapy to Ongoing Antidepressant Treatment in Moderate-to-Severe Major Depressive Disorder: A Randomized Controlled Study 원문보기

International journal of environmental research and public health, v.20 no.1, 2023년, pp.91 -   

Lee, Myungjoo (Department of Medicine, Graduate School, Cha University, Seongnam 13488, Republic of Korea) ,  Choi, Han (Department of Medicine, Graduate School, Cha University, Seongnam 13488, Republic of Korea) ,  Shin, Jiwon (Department of Medicine, Graduate School, Cha University, Seongnam 13488, Republic of Korea) ,  Suh, Ho-Suk (Department of Medicine, Graduate School, Cha University, Seongnam 13488, Republic of Korea)

Abstract AI-Helper 아이콘AI-Helper

This randomized controlled study aimed to investigate the effects of art psychotherapy on moderate-to-severe major depressive disorder (MDD). Forty-two MDD patients were recruited from a psychiatric outpatient clinic in Seoul, the Republic of Korea. Participants were allocated on a randomized, open-...

주제어

참고문헌 (51)

  1. 1. Gutiérrez-Rojas L. Porras-Segovia A. Dunne H. Andrade-González N. Cervilla J.A. Prevalence and correlates of major depressive disorder: A systematic review Rev. Bras. de Psiquiatr. 2020 42 657 672 10.1590/1516-4446-2020-0650 32756809 

  2. 2. Trivedi M.H. Major Depressive Disorder in Primary Care: Strategies for Identification J. Clin. Psychiatry 2020 81 10.4088/JCP.UT17042BR1C 

  3. 3. AFSP Suicide Risk Factors and Warning Signs Available online: https://afsp.org/risk-factors-protective-factors-and-warning-signs#risk-factors (accessed on 26 February 2022) 

  4. 4. CDCP Risk and Protective Factors Available online: https://www.cdc.gov/suicide/factors/ (accessed on 26 February 2022) 

  5. 5. NIMH Suicide Prevention Available online: https://www.nimh.nih.gov/health/topics/suicide-prevention#part_153178 (accessed on 26 February 2022) 

  6. 6. World Health Organisation Suicide: Key Facts 2019 Available online: https://www.who.int/news-room/fact-sheets/detail/suicide (accessed on 16 February 2021) 

  7. 7. Yang L. Zhao Y. Wang Y. Liu L. Zhang X. Li B. Cui R. The Effects of Psychological Stress on Depression Curr. Neuropharmacol. 2015 13 494 504 10.2174/1570159X1304150831150507 26412069 

  8. 8. Ciasca E.C. Ferreira R.C. Santana C.L. Forlenza O.V. dos Santos G.D. Brum P.S. Nunes P.V. Art therapy as an adjuvant treatment for depression in elderly women: A randomized controlled trial Rev. Bras. de Psiquiatr. 2018 40 256 263 10.1590/1516-4446-2017-2250 29412335 

  9. 9. Hays R.D. Wells K.B. Sherbourne C.D. Rogers W. Spritzer K. Functioning and Well-being Outcomes of Patients With Depression Compared With Chronic General Medical Illnesses Arch. Gen. Psychiatry 1995 52 11 19 10.1001/archpsyc.1995.03950130011002 7811158 

  10. 10. Ishak W.W. James D.M. Mirocha J. Youssef H. Tobia G. Pi S. Collison K.L. Cohen R.M. Patient-reported functioning in major depressive disorder Ther. Adv. Chronic Dis. 2016 7 160 169 10.1177/2040622316639769 27347363 

  11. 11. Sumiyoshi T. Watanabe K. Noto S. Sakamoto S. Moriguchi Y. Hammer-Helmich L. Fernandez J. Relationship of Subjective Cognitive Impairment with Psychosocial Function and Relapse of Depressive Symptoms in Patients with Major Depressive Disorder: Analysis of Longitudinal Data from PERFORM-J Neuropsychiatr. Dis. Treat. 2021 17 945 955 10.2147/NDT.S288108 33814911 

  12. 12. Fava G.A. Park S.K. Sonino N. Treatment of recurrent depression Expert Rev. Neurother. 2006 6 1735 1740 10.1586/14737175.6.11.1735 17144786 

  13. 13. Limosin F. Mekaoui L. Hautecouverture S. Stratégies thérapeutiques prophylactiques dans la dépression unipolaire La Presse Médicale 2007 36 1627 1633 10.1016/j.lpm.2007.03.032 17555914 

  14. 14. Culpepper L. Muskin P.R. Stahl S.M. Major Depressive Disorder: Understanding the Significance of Residual Symptoms and Balancing Efficacy with Tolerability Am. J. Med. 2015 128 S1 S15 10.1016/j.amjmed.2015.07.001 26337210 

  15. 15. Eaton W.W. Shao H. Nestadt G. Lee B.H. Bienvenu J. Zandi P. Population-Based Study of First Onset and Chronicity in Major Depressive Disorder Arch. Gen. Psychiatry 2008 65 513 520 10.1001/archpsyc.65.5.513 18458203 

  16. 16. Cuijpers P. Huibers M.J.H. Furukawa T. The Need for Research on Treatments of Chronic Depression JAMA Psychiatry 2017 74 242 243 10.1001/jamapsychiatry.2016.4070 28146256 

  17. 17. Köhler S. Wiethoff K. Ricken R. Stamm T. Baghai T.C. Fisher R. Seemüller F. Brieger P. Cordes J. Malevani J. Characteristics and differences in treatment outcome of inpatients with chronic vs. episodic major depressive disorders J. Affect. Disord. 2014 173 126 133 10.1016/j.jad.2014.10.059 25462406 

  18. 18. Cuijpers P. Turner E.H. Mohr D.C. Hofmann S.G. Andersson G. Berking M. Coyne J. Comparison of psychotherapies for adult depression to pill placebo control groups: A meta-analysis Psychol. Med. 2013 44 685 695 10.1017/S0033291713000457 23552610 

  19. 19. Panel, AHCPR Depression Guideline. Clinical Practice Guideline Number 5. Depression in Primary Care. Volume 2: Treatment of Major Depression. AHCPR Publication no. 93-0550. Rockville (MD): Agency for Health Care Policy and Research Public Health Services, US Department of Health and Human Services Washington, DC, USA 1993 

  20. 20. Gelenberg A.J. Freeman M.P. Markowitz J.C. Rosenbaum J.F. Thase M.E. Trivedi M.H. Van Rhoads R.S. American Psychiatric Association Practice Guideline for the Treatment of Patients With Major Depressive Disorder, Third Edition Am. J. Psychiatry 2010 167 9 118 

  21. 21. Management of Major Depressive Disorder Working Group Clinical Practice Guideline for the Management of Major Depressive Disorder in Adults, Version 2.0 Veterans Health Administration/Department of Defense Washington, DC, USA 2000 

  22. 22. Driessen E. Cuijpers P. de Maat S.C. Abbass A.A. de Jonghe F. Dekker J.J. The efficacy of short-term psychodynamic psychotherapy for depression: A meta-analysis Clin. Psychol. Rev. 2010 30 25 36 10.1016/j.cpr.2009.08.010 19766369 

  23. 23. Karyotaki E. Smit Y. Henningsen K.H. Huibers M. Robays J. de Beurs D. Cuijpers P. Combining pharmacotherapy and psychotherapy or monotherapy for major depression? A meta-analysis on the long-term effects J. Affect. Disord. 2016 194 144 152 10.1016/j.jad.2016.01.036 26826534 

  24. 24. Pampallona S. Bollini P. Tibaldi G. Kupelnick B. Munizza C. Combined pharmacotherapy and psychological treatment for depression: A systematic review Arch. Gen. Psychiatry 2004 61 714 719 10.1001/archpsyc.61.7.714 15237083 

  25. 25. von Wolff A. Hölzel L.P. Westphal A. Härter M. Kriston L. Combination of pharmacotherapy and psychotherapy in the treatment of chronic depression: A systematic review and meta-analysis BMC Psychiatry 2012 12 61 10.1186/1471-244X-12-61 22694751 

  26. 26. Cuijpers P. Noma H. Karyotaki E. Vinkers C.H. Cipriani A. Furukawa T.A. A network meta-analysis of the effects of psychotherapies, pharmacotherapies and their combination in the treatment of adult depression World Psychiatry 2020 19 92 107 10.1002/wps.20701 31922679 

  27. 27. Cuijpers P. Oud M. Karyotaki E. Noma H. Quero S. Cipriani A. Arroll B. Furukawa T.A. Psychologic Treatment of Depression Compared With Pharmacotherapy and Combined Treatment in Primary Care: A Network Meta-Analysis Ann. Fam. Med. 2021 19 262 270 10.1370/afm.2676 34180847 

  28. 28. Bekhuis E. Schoevers R. De Boer M. Peen J. Dekker J. Van H. Boschloo L. Symptom-Specific Effects of Psychotherapy versus Combined Therapy in the Treatment of Mild to Moderate Depression: A Network Approach Psychother. Psychosom. 2018 87 121 123 10.1159/000486793 29495015 

  29. 29. Segal Z. Vincent P. Levitt A. Efficacy of combined, sequential and crossover psychotherapy and pharmacotherapy in improving outcomes in depression J. Psychiatry Neurosci. 2002 27 281 290 12174737 

  30. 30. Ijaz S. Davies P. Williams C.J. Kessler D. Lewis G. Wiles N. Psychological therapies for treatment-resistant depression in adults Cochrane Database Syst. Rev. 2018 2018 CD010558 10.1002/14651858.CD010558.pub2 

  31. 31. Mohacsy I. Nonverbal communication and its place in the therapy session Arts Psychother. 1995 22 31 38 10.1016/0197-4556(94)00060-5 

  32. 32. Malchiodi C.A. Expressive Therapies: History, Theory and Practice McGraw-Hill New York, NY, USA 2005 

  33. 33. Haeyen S. Chakhssi F. Van Hooren S. Benefits of Art Therapy in People Diagnosed With Personality Disorders: A Quantitative Survey Front. Psychol. 2020 11 686 10.3389/fpsyg.2020.00686 32351431 

  34. 34. Mercer A. Warson E. Zhao J. Visual journaling: An intervention to influence stress, anxiety and affect levels in medical students Arts Psychother. 2010 37 143 148 10.1016/j.aip.2009.12.003 

  35. 35. Kramer E. Art as Therapy: Collected Papers Jessica Kingsley Publishers London, UK 2001 

  36. 36. Hanevik H. Hestad K.A. Lien L. Teglbjaerg H.S. Danbolt L.J. Expressive art therapy for psychosis: A multiple case study Arts Psychother. 2013 40 312 321 10.1016/j.aip.2013.05.011 

  37. 37. Nan J.K. Ho R.T. Effects of clay art therapy on adults outpatients with major depressive disorder: A randomized controlled trial J. Affect. Disord. 2017 217 237 245 10.1016/j.jad.2017.04.013 28433887 

  38. 38. Korostiy V. Hmain S. Influence of art therapy in complex treatment on the quality of remission in patients with recurrent depressive disorder Eur. Psychiatry 2016 33 S559 10.1016/j.eurpsy.2016.01.2069 

  39. 39. Choi H. Jung D.-J. Jeon Y.-H. Kim M.J. The effects of combining art psychotherapy with pharmacotherapy in treating major depressive disorder: Randomized control study Arts Psychother. 2020 70 101689 10.1016/j.aip.2020.101689 

  40. 40. Faul F. Erdfelder E. Buchner A. Lang A.-G. Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses Behav. Res. Methods 2009 41 1149 1160 10.3758/BRM.41.4.1149 19897823 

  41. 41. Gilmer W.S. Trivedi M.H. Rush A. Wisniewski S. Luther J. Howland R.H. Yohanna D. Khan A. Alpert J. Factors associated with chronic depressive episodes: A preliminary report from the STAR-D project Acta Psychiatr. Scand. 2005 112 425 433 10.1111/j.1600-0447.2005.00633.x 16279871 

  42. 42. Nieuwsma J.A. Trivedi R.B. McDuffie J. Kronish I. Benjamin D. Williams Jr J.W. Brief psychotherapy for depression: A systematic review and meta-analysis Int. J. Psychiatry Med. 2012 43 129 151 10.2190/PM.43.2.c 22849036 

  43. 43. Klerman G.L. Weissman M.M. Interpersonal Psychotherapy of Depression: A Brief, Focused, Specific Strategy Jason Aronson, Incorporated Lanham, MD, USA 1994 

  44. 44. Hamilton M. A rating scale for depression J. Neurol. Neurosurg. Psychiatry 1960 23 56 10.1136/jnnp.23.1.56 14399272 

  45. 45. Beck A.T. Steer R.A. Brown G.K. Beck Depression Inventory (BDI-II) Pearson London, UK 1996 Volume 10 

  46. 46. Riedel M. Möller H.-J. Obermeier M. Schennach-Wolff R. Bauer M. Adli M. Kronmüller K. Nickel T. Brieger P. Laux G. Response and remission criteria in major depression—A validation of current practice J. Psychiatr. Res. 2010 44 1063 1068 10.1016/j.jpsychires.2010.03.006 20447651 

  47. 47. Zimmerman M. Chelminski I. Posternak M. A review of studies of the Hamilton depression rating scale in healthy controls: Implications for the definition of remission in treatment studies of depression J. Nerv. Ment. Dis. 2004 192 595 601 10.1097/01.nmd.0000138226.22761.39 15348975 

  48. 48. DeRubeis R.J. Hollon S.D. Amsterdam J.D. Shelton R.C. Young P.R. Salomon R. O’Reardon J.P. Lovett M.L. Gladis M.M. Brown L.L. Cognitive Therapy vs Medications in the Treatment of Moderate to Severe Depression Arch. Gen. Psychiatry 2005 62 409 416 10.1001/archpsyc.62.4.409 15809408 

  49. 49. Zu S. Xiang Y.T. Liu J. Zhang L. Wang G. Ma X. Kilbourne A.M. Ungvari G.S. Chiu H.F.K. Li Z.J. A comparison of cognitive-behavioral therapy, antidepressants, their combination and standard treatment for Chinese patients with moderate–severe major depressive disorders J. Affect. Disord. 2014 152 262 267 10.1016/j.jad.2013.09.022 24140226 

  50. 50. Uttley L. Scope A. Stevenson M. Rawdin A. Buck E.T. Sutton A. Stevens J. Kaltenthaler E. Dent-Brown K. Wood C. Systematic review and economic modelling of the clinical effectiveness and cost-effectiveness of art therapy among people with non-psychotic mental health disorders Heal. Technol. Assess. 2015 19 18 10.3310/hta19180 

  51. 51. Springham N. Huet V. Facing our shadows: Understanding harm in the arts therapies Int. J. Art Ther. 2020 25 5 18 10.1080/17454832.2020.1719168 

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로